
About NovoBliss
NovoBliss is a Healthcare company based in Gandhinagar (India) founded in 2021 by Nayan Patel and Maheshvari Patel. It offers clinical trials, regulatory consultancy, and medical services for health innovations. It operates on a B2B model in Healthcare and Consumer sectors. The company has 18 employees. Its chief executive, as recorded, is Nayan Patel. Its website novobliss.in draws about 681 thousand monthly visits. Its Indian entity Novobliss Research Private Limited reported revenue of βΉ4.65 Cr. NovoBliss offers products and services including Regulatory Consultancy, Clinical Services, Biostatistics and Programming, Medical Writing, and Medical Review. Its focus areas include Health and Life Sciences, Clinical Research, Therapeutics and Cosmetic Trials.
Company details
NovoBliss is a company based in Ahmedabad, India, that specializes in clinical research services, regulatory consultancy, and medical writing. They conduct trials for cosmetics, nutraceuticals, and therapeutic products, ensuring compliance and quality. Working with global clients, they advance innovation in health sciences through expert teams and partnerships, focusing on areas like biostatistics and laboratory testing.
- Headquarters Gandhinagar, India
- Employees 18
- Founders Nayan Patel, Maheshvari Patel
- SectorsHealthcareConsumer
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website novobliss.in
- Social LinkedIn Facebook Instagram
- Legal Name Novobliss Research Private Limited
- Date of Incorporation 05 Oct, 2021
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹4.65 Cr
FY 2024 · +142% YoY
- Net Profit₹91.3 Lakh
FY 2024 · 20% margin
- EBITDA₹1.12 Cr
FY 2024 · 24% margin
- Employee Count18
Associated legal entities of NovoBliss
NovoBliss operates through Novobliss Research Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Novobliss Research Private Limited CIN U73200GJ2021PTC126124 | Active | 05 Oct 2021 | Ahmedabad, Gujarat | ₹4.6 Cr | 18 | 2 | View details |
Products & Services of NovoBliss
NovoBliss offers a comprehensive portfolio of products and services, including Regulatory Consultancy, Clinical Services, Biostatistics and Programming, Medical Writing, and Medical Review.
Provides advice on regulatory compliance for health products
Conducts trials for cosmetics and nutraceuticals
Offers statistical analysis for clinical studies
Prepares reports and documents for health research
Performs evaluations for clinical and therapeutic studies
Board of directors of Novobliss Research Private Limited (NovoBliss)
Novobliss Research Private Limited is the primary company behind NovoBliss. The board of Novobliss Research Private Limited currently have 2 directors; the longest-serving is Maheshvari Nayan Patel, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Maheshvari Nayan Patel DIN 09346831 | Director | 05 Oct 2021 | 5 yrs 1 mo | Novobliss Research Private Limited |
| Nayan Kaushikbhai Patel DIN 09346832 | Director | 05 Oct 2021 | 5 yrs 1 mo | Novobliss Research Private Limited |
People of NovoBliss
2 people are tracked at NovoBliss (2 in leadership); the tracked headcount is 18.
| Name | Role | Group |
|---|---|---|
| Co-Founder, CEO | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for NovoBliss
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of NovoBliss
Figures of Novobliss Research Private Limited, the primary company behind NovoBliss, for FY 2024. Revenue was ₹4.65 Cr (+142% year on year). Net profit was ₹91.3 Lakh (20% margin). EBITDA was ₹1.12 Cr (24% margin).
- ₹4.65 CrRevenue · FY 2024 · +142% YoY
- ₹91.3 LakhNet profit · 20% margin
- ₹1.12 CrEBITDA · 24% margin
- ₹1 LakhPaid-up capital
- 18Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Novobliss Research Private Limited are on its company page.
Detailed financial statements for NovoBliss
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of NovoBliss
The website of NovoBliss (novobliss.in) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with NovoBliss. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for NovoBliss
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
2 companies that operate in the same segment as NovoBliss (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | USD 74.68 M | 1,618 | ||
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | USD 4.22 M | 228 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NovoBliss
NovoBliss was founded in 2021.
NovoBliss is headquartered in Gandhinagar, India. It is registered at Gandhinagar, Gujarat, India.
Nayan Patel is the CEO of NovoBliss, as recorded in our data. They have also founded this company.
NovoBliss has 18 employees.
The primary company behind NovoBliss, Novobliss Research Private Limited, reported revenue of βΉ4.65 Cr for FY 2024, up 142% year on year.
NovoBliss is a company based in Ahmedabad, India, that specializes in clinical research services, regulatory consultancy, and medical writing. They conduct trials for cosmetics, nutraceuticals, and therapeutic products, ensuring compliance and quality. Working with global clients, they advance innovation in health sciences through expert teams and partnerships, focusing on areas like biostatistics and laboratory testing.
NovoBliss offers Regulatory Consultancy, Clinical Services, Biostatistics and Programming, Medical Writing, and Medical Review.
NovoBliss operates through Novobliss Research Private Limited.
The legal entities of NovoBliss currently have 2 directors, including Maheshvari Nayan Patel, Nayan Kaushikbhai Patel.
The website of NovoBliss receives about 681 thousand visits a month.